Switch to:

Horizon Therapeutics Equity-to-Asset

: 0.52 (As of Jun. 2020)
View and export this data going back to 2011. Start your Free Trial

Equity to Asset ratio is calculated as shareholder's tangible equity divided by its total asset. Horizon Therapeutics's Total Stockholders Equity for the quarter that ended in Jun. 2020 was $2,362 Mil. Horizon Therapeutics's Total Assets for the quarter that ended in Jun. 2020 was $4,538 Mil. Therefore, Horizon Therapeutics's Equity to Asset Ratio for the quarter that ended in Jun. 2020 was 0.52.

NAS:HZNP' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.77   Med: 0.43   Max: 0.7
Current: 0.52

-0.77
0.7

During the past 12 years, the highest Equity to Asset Ratio of Horizon Therapeutics was 0.70. The lowest was -0.77. And the median was 0.43.

NAS:HZNP's Equity-to-Asset is ranked lower than
59% of the 958 Companies
in the Drug Manufacturers industry.

( Industry Median: 0.59 vs. NAS:HZNP: 0.52 )

Horizon Therapeutics Equity-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Horizon Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.29 0.24 0.30 0.49

Horizon Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.42 0.49 0.51 0.52

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Horizon Therapeutics Equity-to-Asset Distribution

* The bar in red indicates where Horizon Therapeutics's Equity-to-Asset falls into.



Horizon Therapeutics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing shareholder's tangible equity divided by its total asset.

Horizon Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Equity to Asset (A: Dec. 2019 )=Total Stockholders Equity/Total Assets
=2185.449/4436.034
=0.49

Horizon Therapeutics's Equity to Asset Ratio for the quarter that ended in Jun. 2020 is calculated as

Equity to Asset (Q: Jun. 2020 )=Total Stockholders Equity/Total Assets
=2361.852/4538.191
=0.52

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Horizon Therapeutics  (NAS:HZNP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Horizon Therapeutics Equity-to-Asset Related Terms


Horizon Therapeutics Equity-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)